PMID-sentid	Pub_year	Sent_text		comp_official_name	comp_offsetprotein_name	organism	prot_offset
35462331-5	2022	Midostaurin, identified as an ABCB1 inhibitor, increased anthracycline accumulation in peripheral blood mononuclear cells (PBMC) of CD34+ AML patients and those not achieving CR.	midostaurin	0-11	CD34 molecule	Homo sapiens	132-136	
35462331-9	2022	Overall, we highlight the therapeutic value of midostaurin as more than just a FLT3 inhibitor, suggesting its maximal therapeutic outcomes might be very sensitive to proper timing and well-optimized dosage schemes based upon patient"s characteristics, such as CD34 positivity and ABCB1 activity.	midostaurin	47-58	CD34 molecule	Homo sapiens	260-264